4basebio (LSE:4BB) COGS-to-Revenue : 0.32 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio COGS-to-Revenue?

4basebio's Cost of Goods Sold for the six months ended in Jun. 2023 was £0.08 Mil. Its Revenue for the six months ended in Jun. 2023 was £0.24 Mil.

4basebio's COGS to Revenue for the six months ended in Jun. 2023 was 0.32.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. 4basebio's Gross Margin % for the six months ended in Jun. 2023 was 67.65%.

4basebio COGS-to-Revenue Historical Data

The historical data trend for 4basebio's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio COGS-to-Revenue Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

1.14

0.41

0.20

0.11

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial			0.21	0.19	0.24	-0.07	0.32

4basebio COGS-to-Revenue Calculation

4basebio's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.029	/	0.268
	=	0.11

4basebio's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.077	/	0.238
	=	0.32

4basebio (LSE:4BB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

4basebio's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.077 / 0.238
	=	67.65 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

4basebio COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of 4basebio's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (LSE:4BB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

88Q:Germany

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines